Discriminative stimulus effects of GHB and GABAB agonists are differentially attenuated by CGP35348

被引:13
作者
Carter, Lawrence P.
Chen, Weibin
Coop, Andrew
Koek, Wouter
France, Charles P.
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78229 USA
[3] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
关键词
gamma-hydroxybutyrate; GHB; baclofen; SKF97541; GABA; Xyrem; sodium oxybate; drug discrimination;
D O I
10.1016/j.ejphar.2006.03.039
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to examine the possible heterogeneity of mechanisms that contribute to the discriminative stimulus and rate-decreasing effects of gamma-hydroxybutyrate (GHB). Dose effect curves were determined for GHB and two GABA(B) receptor agonists (baclofen and SKF97541) alone and together with the selective GABA(B) receptor antagonist CGP35348 in rats discriminating GHB. In a second study, GHB and SKF97541 dose effect curves were determined alone and together with baclofen. CGP35348 attenuated the discriminative stimulus and rate-decreasing effects of SKF97541 and baclofen to a greater extent than those of GHB. In the second study, baclofen enhanced the discriminative stimulus and rate-decreasing effects of GHB and SKF97541; however, the GHB dose effect curve was not shifted in a parallel manner. Taken together, these data suggest that multiple mechanisms, possibly including GHB receptors and GABA(B) receptor subtypes, are involved in the discriminative stimulus and rate-decreasing effects of GHB. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:85 / 93
页数:9
相关论文
共 64 条
[1]  
Addolorato G, 1996, ALCOHOL ALCOHOLISM, V31, P341
[2]  
BANERJEE PK, 1995, J PHARMACOL EXP THER, V273, P1534
[3]   The role of an international nightlife resort in the proliferation of recreational drugs [J].
Bellis, MA ;
Hughes, K ;
Bennett, A ;
Thomson, R .
ADDICTION, 2003, 98 (12) :1713-1721
[4]   HIGH-AFFINITY BINDING-SITE FOR GAMMA-HYDROXYBUTYRIC ACID IN RAT-BRAIN [J].
BENAVIDES, J ;
RUMIGNY, JF ;
BOURGUIGNON, JJ ;
CASH, C ;
WERMUTH, CG ;
MANDEL, P ;
VINCENDON, G ;
MAITRE, M .
LIFE SCIENCES, 1982, 30 (11) :953-961
[5]  
BERNASCONI R, 1992, J NEURAL TRANSM-GEN, P155
[6]  
BONANNO G, 1992, J PHARMACOL EXP THER, V262, P114
[7]  
BOYD AJ, 1992, CIRC SHOCK, V38, P115
[8]   Fatalities associated with the use of γ-hydroxybutyrate and its analogues in Australasia [J].
Caldicott, DGE ;
Chow, FY ;
Burns, BJ ;
Felgate, PD ;
Byard, RW .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (06) :310-+
[9]   Protection by the GABAB receptor antagonist, SCH 50911, of γ-hydroxybutyric acid-induced mortality in mice [J].
Carai, MAM ;
Colombo, G ;
Gessa, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 503 (1-3) :77-80
[10]   GABAB-receptor mediation of the inhibitory effect of γ-hydroxybutyric acid on intestinal motility in mice [J].
Carai, MAM ;
Agabio, R ;
Lobina, C ;
Reali, R ;
Vacca, G ;
Colombo, G ;
Gessa, GL .
LIFE SCIENCES, 2002, 70 (25) :3059-3067